Observational studyJMIR cancer2026

Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.

Lemchukwu Amaeshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.